Court Rules to Take Regeneron’s Praluent off the Market
Yesterday a US court issued a permanent injunction prohibiting Regeneron (REGN) from selling Praluent in the US. Profit estimates will be coming down.
Yesterday a US court issued a permanent injunction prohibiting Regeneron (REGN) from selling Praluent in the US. Profit estimates will be coming down.
China’s leading search engine, Baidu.com (BIDU), used to be a star in the stock market. Now the company isn’t growing sales or profits.
Buffalo Wild Wings (BWLD) is dealing with slow traffic and higher wing prices. But its new lunch specials, half-price wing Tuesdays, and rewards programs should boost sales.
Sluggish traffic and lower prices continue to hurt Dollar General (DG). But if you sell now, you could get left behind.
Starbucks’ (SBUX) CEO Howard Schultz is stepping aside in April, but the plans for Starbucks to conquer the world are already set in motion.
Shares of VIsa (V) are almost always overvalued — and justifiably so. But now for the first time in a long time V is a good value.
Non-surgical cosmetic procedures are the rage right now, and CynoSure (CYNO) machines can remove tattoos, wrinkles and even unwanted body fat.
Home Depot (HD) continues to grow profits in the teens as same store sales growth and stock buybacks lead the charge.
Celgene (CELG) is having another banner year with profits expected to climb 26% this year. But like many growth stocks, CELG is stuck in neutral.
Salesforce.com (CRM) usually has an enourmous P/E ratio — and rightly so. But after a year of flatlining the multiple is at one of the lowest points in years.
Chinese mobile social network platform Momo (MOMO) is like a Russian girl in a 007 movie. Beautiful and alluring, yet could be dangerous.
News of a better economy is good for Ultimate Software (ULTI), which has human resources software that companies utilize via the cloud.